0,140€
34,38%
Echtzeit-Aktienkurs EXACT THERAP. AS NK 0,004
Bid:
Ask:
Echtzeit-Chart der EXACT THERAP. AS NK 0,004 Aktie
Fundamentaldaten der EXACT THERAP. AS NK 0,004 Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2024 [NOK] | - | -52,33 Mio. | -52,33 Mio. | -1,51 | - | - | - |
| 2023 [NOK] | - | -48,38 Mio. | -48,33 Mio. | -1,51 | - | - | - |
| 2022 [NOK] | - | -40,57 Mio. | -40,10 Mio. | -1,34 | - | - | - |
| 2021 [NOK] | - | -58,59 Mio. | -58,59 Mio. | -1,95 | - | - | - |
| 2020 [NOK] | - | -33,09 Mio. | -33,09 Mio. | -2,20 | - | - | - |
| 2019 [NOK] | 0,09 Mio. | -14,98 Mio. | -14,98 Mio. | -0,50 | - | - | 47,46 |
| 2018 [NOK] | - | -7,59 Mio. | -7,59 Mio. | -0,25 | - | - | - |
| 2017 [NOK] | 0,16 Mio. | -4,91 Mio. | -4,91 Mio. | -0,16 | - | - | 25,74 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der EXACT THERAP. AS NK 0,004 Aktie
EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. It focuses on Acoustic Cluster Therapy (ACT) platform, an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology, infectious diseases, and neurological conditions. The company was founded by Svein Kvale, Per Christian Sontum, and Andrew John Healey in 2012 and is headquartered in Oslo, Norway.